{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":4,"sponsored":0,"items":[{"id":"n_o2nxmki3byikpybshhwa","seq":1266846,"kind":"article","title":"Lilly's Foundayo Pill Matched Insulin on Heart Safety in Lancet Trial, but Its Lower Death Rate Needs Caution","url":"https://www.medicaldaily.com/foundayo-orforglipron-achieve-4-lancet-heart-safety-insulin-479387","summary":"Lilly's Foundayo pill met a heart-safety test against insulin in a Lancet trial. Fewer deaths were seen, but that result is secondary.","published":"2026-10-02T03:22:18Z","seen":"2026-10-02T04:54:28Z","lang":"en","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com","outlet":{"wikidata":"Q69052919","name":"Medical Daily","type":"website","country":"US","designations":["website"]}},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q120491908","name":"orforglipron","type":"other"}],"mentions":2,"story":"st_o2nxmki3byikpybshhwa","category":"health","category_p":0.7,"sentiment":"neutral","tone":0.04,"political":0.01},{"id":"n_wpesggivik3aor6gkvhq","seq":627542,"kind":"article","title":"Lilly's Foundayo Tops Oral Semaglutide In New Diabetes Analysis","url":"https://www.rttnews.com/3694673/lilly-s-foundayo-tops-oral-semaglutide-in-new-diabetes-analysis.aspx","published":"2026-09-29T08:44:00Z","seen":"2026-09-29T09:25:18Z","lang":"en","source":{"id":"rttnews.com","name":"rttnews.com","domain":"rttnews.com","outlet":{"wikidata":"Q60748698","name":"RTTNews","type":"news_agency","designations":["news agency","news website"]}},"via":"gdelt-gkg-english","topics":["economy","health","business"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q120491908","name":"orforglipron","type":"org"},{"id":"Q27261089","name":"semaglutide","type":"other"}],"story":"st_wpesggivik3aor6gkvhq","category":"health","category_p":0.53,"sentiment":"positive","tone":0.02,"political":0.01},{"id":"n_qvwfbu3hqhmwyiffgi4a","seq":385705,"kind":"article","title":"New diabetes pill orforglipron achieves uniform weight loss for women of all ages","url":"https://www.news-medical.net/news/20260928/New-diabetes-pill-orforglipron-achieves-uniform-weight-loss-for-women-of-all-ages.aspx","summary":"New analyses to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) show that the new daily oral weight loss / type 2 diabetes medication orforglipron was associated with similar weight loss for women of different ages and at different life stages – premenopausal, experiencing menopause, or post-menopausal. The study is by Dr Hunter Thomas Hoffman, Eli Lilly and Company, Indianapolis, IN, USA – the…","published":"2026-09-28T08:48:00Z","seen":"2026-09-28T09:16:59Z","lang":"en","source":{"id":"kite-news-medical-net-491c44","name":"news-medical.net","domain":"news-medical.net"},"via":"kite-news-medical-net-491c44","topics":["medicine"],"entities":[{"id":"Q120491908","name":"orforglipron","type":"other"}],"image":"https://www.news-medical.net/image-handler/picture/2014/7/weight_loss-620x480.jpg","mentions":2,"story":"st_qvwfbu3hqhmwyiffgi4a","category":"health","category_p":0.78,"sentiment":"positive","tone":0.53,"political":0.02},{"id":"n_bqjkgttr2antu7bdxdra","seq":307912,"kind":"article","title":"Lilly's Oral GLP-1 Push Gains Momentum. Can Foundayo Become its Next Growth Engine?","url":"https://www.insidermonkey.com/news/lillys-oral-glp-1-push-gains-momentum-can-foundayo-become-its-next-growth-engine-1845136","published":"2026-09-27T22:21:40Z","seen":"2026-09-27T22:21:40Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["economy","health","business"],"authors":["Vardah Gill"],"entities":[{"id":"Q120491908","name":"orforglipron","type":"other"}],"story":"st_bqjkgttr2antu7bdxdra","category":"economy-business","category_p":0.74,"sentiment":"positive","tone":0.26,"political":0.03}]}